文献速递间质性肺疾病

间质性肺疾病疲劳与呼吸困难(ILD-FAB)项目:一项多学科可行性研究

Interstitial lung disease fatigue and breathlessness (ILD-FAB) programme: a multidisciplinary feasibility study
RSS 订阅 · BMJ Open Respiratory Research

该研究评估将疲劳与呼吸困难(FAB)项目适配于间质性肺疾病(ILD)患者的可行性。2023年3月至2024年12月开展11组、每组≤6人的4周项目,49名参与者中37人完成前后慢性呼吸问卷(CRQ-SR),59%呼吸困难、51%情绪功能、49%疲劳与掌控感评分达临床显著改善,95%至少一个领域改善,全部参与者愿意推荐该项目。

要点

  • 4周ILD-FAB项目由ILD专科物理治疗师与临床护理专家带领,每组≤6人,每周2小时。
  • 37名完成CRQ-SR者中,59%呼吸困难、51%情绪功能、49%疲劳与掌控感评分达临床显著改善。
  • 35名(95%)至少一个领域达临床显著改善,全部参与者愿意向他人推荐该项目。

核心结论

  • 这些数据表明ILD专用FAB项目具有可行性、可接受性和临床有效性。
  • 进一步研究将在更大队列中纵向探索一系列结局指标。

研究设计与样本

  • 研究为ILD-FAB项目的多学科可行性研究,项目为期4周,每组≤6人,每周2小时,由ILD专科物理治疗师和临床护理专家带领。
  • 2023年3月至2024年12月共开展11组。
  • 49名参与者(26名男性;中位年龄76岁(IQR=14))诊断为特发性肺纤维化(n=21)、进展性肺纤维化(n=17)或不同病因的非进展性ILD(n=11)。
  • 肺功能显示疾病严重程度范围:FVC占预计值中位数70%(IQR=34);DLCO占预计值中位数42%(IQR=30)。
  • 采用自评慢性呼吸问卷(CRQ-SR)在基线和4周后评估呼吸困难、疲劳、情绪功能和掌控感。

主要发现

  • 37名(76%)参与者完成全部四次课程,6名(12%)完成三次,2名(4%)完成两次,4名(8%)完成一次。
  • 37名参与者(均至少完成三次课程)在基线和第4周完成CRQ-SR。
  • 59%的应答者(n=22)呼吸困难评分达临床显著改善,51%(n=19)情绪功能评分达临床显著改善,49%(n=18)疲劳和掌控感评分达临床显著改善。
  • 35名应答者(95%)至少一个领域达临床显著改善。
  • 全部参与者(100%)愿意向他人推荐该项目。

局限性

  • 进一步研究将在更大队列中纵向探索一系列结局指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background Fatigue, breathlessness and cough are prevalent symptoms of interstitial lung disease (ILD) adversely impacting quality of life and contributing to psychological distress. The fatigue and breathlessness (FAB) programme facilitates supported self-management for people living with life-limiting conditions. We explore its utility when adapted for people living with ILD. Methods The 4-week ILD-FAB programme offers each group (n=≤6) weekly 2-hour sessions led by an ILD-specialist physiotherapist and clinical nurse specialist (CNS). Primary focus is on strategies to manage breathlessness, fatigue and well-being. Further, a 1:1 session with the ILD-CNS enables participants to set personalised goals and explore individual health beliefs/behaviours using a cognitive behavioural therapy assessment framework. The self-reporting chronic respiratory questionnaire (CRQ-SR) evaluates breathlessness, fatigue, emotional function and mastery at baseline and after 4 weeks. We facilitated 11 groups between March 2023 and December 2024. Results 49 participants (26 males; median age 76 years (IQR=14)) were diagnosed with idiopathic pulmonary fibrosis (n=21), progressive pulmonary fibrosis (n=17) or non-progressive ILD (n=11) of various aetiologies. Lung function indicated a range of disease severity (FVC % predicted median: 70% (IQR=34); DLCO % predicted median: 42% (IQR=30)). 37 (76%) participants attended all four sessions, 6 (12%) attended three sessions, 2 (4%) attended two sessions and 4 (8%) attended one session. 37 patients, all of whom attended at least three sessions, completed the CRQ-SR at baseline and week 4. 59% of respondents (n=22) demonstrated clinically significant improvements in dyspnoea scores, 51% (n=19) in emotional functioning scores and 49% (n=18) in fatigue and mastery scores. 35 respondents (95%) demonstrated a clinically significant improvement in at least one domain. All participants (100%) would recommend this programme to others. Conclusion These data demonstrate feasibility, acceptability and clinical effectiveness of an ILD-specific FAB programme. Further research will explore a range of outcome measures longitudinally in a larger cohort.

来源:BMJ Open Respiratory Research,查看原文。版权归原作者所有。

引用

  1. BMJ Open Respiratory Research:Interstitial lung disease fatigue and breathlessness (ILD-FAB) programme: a multidisciplinary feasibility study

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。